Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 02/11/2025 12:35:43 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 996
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
16573
Sox Leo has the perfect opportunity for a deal
leedom
12/16/2015 1:57:47 PM
16572
I suggest you to read the latest 10-Q. Itll
sox0407
12/16/2015 1:51:07 PM
16571
Drano that stuff means nothing. We are down 5%
leedom
12/16/2015 1:46:55 PM
16570
200k trade in one minute. Here's a 1-minute
Drano
12/16/2015 1:41:29 PM
16569
In the green now on today's new stock
Drano
12/16/2015 12:55:29 PM
16568
I worked with a guy who was a type1 diabetic. He
leedom
12/16/2015 12:55:07 PM
16567
Trolls? We have $7.7mm to do all these trials.
leedom
12/16/2015 12:52:08 PM
16566
The article Dana-Farber submitted about Kevetrin
Drano
12/16/2015 12:44:35 PM
16565
The FUD claims of CTIX needing more money, having
Drano
12/16/2015 12:42:06 PM
16564
Kevetrin does have the long lasting effect of
sox0407
12/16/2015 12:41:29 PM
16561
SOX we are looking at 6+ trials in 2016. $7.7mm
leedom
12/16/2015 12:32:07 PM
16560
Dilutions have been minimal over the years. If
sox0407
12/16/2015 11:59:20 AM
16558
Theory about the U of Bologna Kevetrin trial
Drano
12/16/2015 11:56:41 AM
16554
Attention Mac users: Chrome seems to work much
Drano
12/16/2015 11:42:05 AM
16553
imaginary shares? LMAO! I love the science and
leedom
12/16/2015 11:41:23 AM
16552
All excellent points/info, doubleJ23. The
Drano
12/16/2015 11:39:26 AM
16551
According to articles, good liars try to make
Drano
12/16/2015 11:34:54 AM
16550
Also, even though Leo mentions the ABSSSI market
doubleJ23
12/16/2015 11:28:58 AM
16549
Look if you are going to pretend to own the
F1ash
12/16/2015 11:27:29 AM
16548
There must be something positive about the
sox0407
12/16/2015 11:22:16 AM
16547
Thanks again doubleJ23. I agree that they are
Drano
12/16/2015 11:20:11 AM
16546
So we are down 10% on 250,000
leedom
12/16/2015 11:18:21 AM
16545
That was posted on Yahoo...I guess my assessment
leedom
12/16/2015 11:16:32 AM
16544
Congrats to all of us here who have evidently
Drano
12/16/2015 11:14:42 AM
16543
Thanks for letting us know your other name at
Drano
12/16/2015 11:12:08 AM
16542
Believe me, it was on the tip of my tongue when
doubleJ23
12/16/2015 11:09:12 AM
16541
Thanks for your posts.
ready2rock
12/16/2015 11:06:03 AM
16540
$1.33 well apparently there must be a lot of
leedom
12/16/2015 11:02:42 AM
16539
You may have seen that Solgenix just reported
Drano
12/16/2015 10:49:51 AM
16538
Drano I'm lee122oneill over on the Y board. and
leedom
12/16/2015 10:49:50 AM
16537
That was my guess too. We knew that the bashers
Drano
12/16/2015 10:38:39 AM
16536
Please tell us what name you post under at the
Drano
12/16/2015 10:32:50 AM
16535
You can count on it that someone from the short
Drano
12/16/2015 10:30:29 AM
16534
Your last four posts are all downers. Your posts
thefamilyman
12/16/2015 10:24:36 AM
16533
Somebody keeps bidding for a lot of
grotty
12/16/2015 10:14:16 AM
16532
Science is awesome and Leo has shareholders best
AlanC
12/16/2015 10:08:08 AM
16531
He did not rule it out either. It would depend on
scgmck1
12/16/2015 10:00:37 AM
16530
I bought more at 1.44
grotty
12/16/2015 9:59:47 AM
16529
It was a great meeting and the future is bright
AlanC
12/16/2015 9:59:28 AM
16528
AlanC Science is NO GOOD if you don't have the
leedom
12/16/2015 9:58:02 AM
16527
Your reaction is exactly the reason they would
AlanC
12/16/2015 9:56:12 AM
16526
In all likelihood and Leo agrees Rosen will get a
leedom
12/16/2015 9:56:11 AM
16525
Testing
grotty
12/16/2015 9:55:05 AM
16524
$1.42 Yea great meeting!
leedom
12/16/2015 9:53:41 AM
16523
$1.47 I guess Leo saying no deal until Phase3
leedom
12/16/2015 9:45:16 AM
16522
The support for this site is growing. Similar
AlanC
12/16/2015 9:40:54 AM
16521
Drano: Think about CTIX this way: There are no
AlanC
12/16/2015 9:33:44 AM
16520
I believe it's related to safety studies for
biodoc
12/16/2015 9:28:41 AM
16519
I wonder if he knows about Kevetrin?
leedom
12/16/2015 9:26:49 AM
16518
Welcome thttlpckg. Your concerns are shared here
scgmck1
12/16/2015 9:26:42 AM
Newer
Older
Recent Articles
Healthcare Sector Gains Momentum, Financial Stocks Struggle Ahead
Recce Pharmaceuticals Secures Patent for Innovative Anti-Infectives
MiMedx Group: Exciting Participation at Healthcare Conference
Vera Therapeutics' Upcoming Participation in Key Health Event
ZenaTech's IQ Square Drone Enters Manufacturing for Diverse Uses
Fusion Fuel Strengthens Board with Luisa Ingargiola Appointment
TruGolf Partners with Eventus for Financial Stability and Growth
Cogent Biosciences Shares Positive SUMMIT Trial Results for COGT
Ayurcann Holdings Corp. Announces Exceptional Q2 Growth
Navigating the Future: Key Software Development Challenges Ahead
MovieCoin Revolutionizes Film Financing with Blockchain Innovation
CytomX Therapeutics Announces Full Year 2024 Results Timetable
Xometry to Showcase Innovations at Upcoming Technology Conference
nextSource Elevates Leadership with New COO to Enhance Growth
Forecast for Battery Recycling Market Growth to $54.3 Billion
VERSES AI Welcomes James Christodoulou as New CFO
Rising Automotive Piezoelectric Actuators Market Insight
Xpeng's CEO Embraces Tesla's FSD Launch in China
Navigating Market Trends and Analyzing Key Stock Movements
Tesla CEO Elon Musk Faces Significant Wealth Reduction Amid Stock Drop
Harnessing Waste Gas for Sustainable Energy and Bitcoin Mining
Greenlane Renewables Outlines Vision for 2025 with Strategic Plan
Arcuro Medical's SuperBall RC Revolutionizes Rotator Cuff Repairs
Santacruz Silver's San Lucas S.A. Celebrates Note Offering Success
NexPoint Real Estate Finance Reports Q4 Results and 2025 Outlook
FEMSA Announces Stellar Q4 and Full-Year Financial Performance
Mole Street and Datava Team Up for Credit Union Innovation
Savor the Ultimate Flavor with Red Robin's New Burger Delight
Elevating Connections: Exquisite Elite Matchmaking Event Insights
Zinzino AB Reports Record Growth and Dividend Proposal
SAP Unveils Comprehensive Reports Highlighting Future Growth
NexPoint Real Estate Finance Reports Strong Q4 Results
Daxor Corporation Enhances Blood Volume Measurement Across Hospitals
HawkEye 360 Restructures Leadership for Future Success
Unlocking Gold and Antimony Potential at Limousine Butte Project
Navigating Tariff Changes Impacting North American Trade
Intuitive Machines' Historic Lunar Lander En Route to Moon's Orbit
FEMSA Reports Strong Growth for Fourth Quarter and Year-End
electroCore Partners to Distribute Innovative Opioid Treatment
authID Set to Reveal Key Financial Insights Soon
PMGC Holdings Enhances Growth Potential Through Strategic Alliance
Apyx Medical Corporation's Upcoming Q4 2024 Financial Release
Adagene Launches New Trial for Colorectal Cancer Treatment
CoreCivic Expands Capacity for Immigration Detention Facilities
Recent Financial Insights and Clinical Updates at Disc Medicine
Entrada Therapeutics Delivers Recent Progress and 2024 Results
Innovative Partnership to Revolutionize Satellite Connectivity
NEXE Innovations Expands Reach with New Partnership in North America
Verve Therapeutics Makes Strides in Genetic Medicines for Heart Health
Desjardins Unveils New ETF Focused on Emerging Markets